|1.||Sun, Buxiang: 8 articles (10/2009 - 08/2003)|
|2.||Fujii, Hajime: 6 articles (10/2009 - 10/2006)|
|3.||Sonnenfeld, Gerald: 4 articles (04/2008 - 08/2003)|
|4.||Aviles, Hernan: 4 articles (04/2008 - 08/2003)|
|5.||Kuramitsu, Yasuhiro: 3 articles (11/2015 - 01/2014)|
|6.||Zarzuelo, Antonio: 3 articles (12/2014 - 05/2007)|
|7.||Martínez-Augustin, Olga: 3 articles (12/2014 - 05/2007)|
|8.||Nishioka, Hiroshi: 3 articles (10/2009 - 07/2007)|
|9.||Kitagawa, Takao: 2 articles (11/2015 - 09/2014)|
|10.||Tokuda, Kazuhiro: 2 articles (11/2015 - 09/2014)|
|1.||Hepatocellular Carcinoma (Hepatoma)
08/31/2014 - "Supplementation of active hexose correlated compound (AHCC) improved the prognosis of postoperative hepatocellular carcinoma patients. "
04/01/2015 - "Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-bearing mice."
07/01/2011 - "The purpose of this review is to present the currently published evidence regarding the use, efficacy, potential mechanisms of action, and results of published clinical trials regarding the use of a Lentinula edodes mushroom-derived extract (active hexose correlated compound) as complementary therapy in patients with cancer. "
12/01/2015 - "While Active Hexose Correlated Compound (AHCC) and CpG oligodeoxynucleotide (ODN) are separately known to modulate oxidative stress and immune responses in cancer patients, the combined effect of these two compounds is unknown. "
01/01/2009 - "Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice."
07/15/2007 - "The active hexose correlated compound (AHCC) is an extract of Basidiomycotina marketed as a supplement for cancer patients due to its nutrients and fibre content and its ability to strengthen and optimize the capacity of the immune system. "
10/01/2006 - "Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses."
04/01/2008 - "The objective of this study was to clarify the mechanisms by which active hexose correlated compound (AHCC) increases survival in a murine model of intramuscular infection. "
02/01/2009 - "Supplementation with mushroom-derived active hexose correlated compound (AHCC) modulates immunity and increases survival in response to a broad spectrum of acute infections, including influenza virus infection. "
04/01/2008 - "Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection."
10/01/2004 - "It has been shown that treatment with active hexose correlated compound (AHCC) restores resistance to infection in mice maintained under hindlimb-unloading conditions. "
08/01/2003 - "Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions."
|4.||Soft Tissue Infections
12/01/2015 - "Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model."
12/01/2015 - "Collectively, our study indicates therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with KSK-CpG ODN in B16 melanoma murine model via balancing redox and cytokines network. "
|7.||Transcription Factors (Transcription Factor)
|1.||Drug Therapy (Chemotherapy)